Skip to main content

Karmar

Industry and technology

ONCO BCG Drug Manufacturing Plant

LocationLublin
ClientSYNTHAVERSE
Delivery2023

A State-of-the-Art Facility for Pharmaceutical Manufacturing and Research

Key data:

  • Location: Lublin, Poland
  • Client: SYNTHAVERSE SPÓŁKA AKCYJNA 
  • General Contractor: KARMAR S.A.
  • Completion: 2024
  • Gross Floor Area: 3,250 m²
  • Usable Floor Area: 2,913 m²
  • Building Footprint: 1,509 m²
  • Building Volume: 18,455 m³
  • Number of floors: 2
  • Cleanroom Classification: Grades A-D

 

KARMAR delivered the ONKO BCG facility for SYNTHAVERSE SPÓŁKA AKCYJNA, including the construction of the building together with all required technical and technological infrastructure. The facility was designed to support pharmaceutical manufacturing and product development processes while meeting the stringent requirements of the life science sector.

The scope of works included the preparation of detailed design documentation, construction and installation works, delivery and commissioning of specialized technological systems, as well as validation and qualification processes required for pharmaceutical facilities.

Advanced Technologies and the Highest Quality Standards

The project incorporated specialized solutions dedicated to pharmaceutical production environments, including Grade A-D cleanrooms and advanced process and utility systems. The facility was equipped with systems for the generation of Water for Injection (WFI), Clean Steam and Purified Water to support laboratory and manufacturing operations.

The project was delivered in accordance with the highest standards of design, construction and facility qualification. The performance of installed systems and compliance with pharmaceutical industry requirements were validated through comprehensive qualification and validation processes, including DQ, IQ and OQ.

ONKO BCG is an example of an advanced life science investment combining modern technologies, specialized infrastructure and the highest quality standards required for pharmaceutical manufacturing and research and development activities.

Gallery

mg 2596mg 2640 kopiamg 2631 kopiamg 2616 kopiadji 0571 kopiadji 0521 bez stodoły kopia
Go back to Projects

Other projects

Wydział Produkcji Form Sterylnych i Laboratoria Badawczo-Rozwojowe, etap IITZF Polfa – Sterile Dosage Forms Manufacturing Facility and Research & Development LaboratoriesviewHala testów opon i rozbudowa laboratoriumNew Tire Testing Hall and Michelin Laboratory ExpansionviewCentrum Badawczo-RozwojoweResearch & Development CenterviewPrzebudowa laboratorium Polpharma BiologicPrzebudowa laboratorium Polpharma BiologicviewMODERNIZACJA CDMO MABION S.A.Modernization of the CDMO Facility of Mabion S.A.viewPolpharma II – Przebudowa i adaptacja powierzchni: zaplecze badawczo rozwojowe i produkcyjnePolpharma II - Reconstruction and Adaptation of R&D and Production AreasviewHala testów i odbiorów Alstom KonstalAlstom Konstal Test and Acceptance HallviewPolpharma ABCD – Centrum Produkcyjno-LogistycznePolpharma ABCD - Production and Logistics CenterviewPrzebudowa magazynu C na Strefę Rozwoju i Optymalizacji Procesów BiotechnologicznychConversion of a Warehouse C into a Biotechnology Process Development and Optimization AreaviewWarsztat Utrzymania Technicznego PKP IntercityTechnical Maintenance DepotviewGdański Park Naukowo-Technologiczny im. prof. H. Koprowskiego, Budynki A i BThe Prof. H. Koprowski Gdańsk Science and Technology Park, Buildings A, Bview